Company · Laval, Quebec, Canada
Pro Doc Limitee
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 776
- 346 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 600
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ALENDRONATE-70 | 02303078 | Marketed | |
| ALLOPURINOL-100 | 00555681 | Marketed | |
| ALLOPURINOL-200 | 02130157 | Marketed | |
| ALLOPURINOL-300 | 00555703 | Marketed | |
| ALMOTRIPTAN | 02424029 | Marketed | |
| AMLODIPINE | 02326795 | Marketed | |
| AMLODIPINE | 02326809 | Marketed | |
| AMLODIPINE | 02326817 | Marketed | |
| ARIPIPRAZOLE | 02488000 | Marketed | |
| ARIPIPRAZOLE | 02488019 | Marketed | |
| ARIPIPRAZOLE | 02488027 | Marketed | |
| ARIPIPRAZOLE | 02488035 | Marketed | |
| ARIPIPRAZOLE | 02488043 | Marketed | |
| ARIPIPRAZOLE | 02488051 | Marketed | |
| CANDESARTAN | 02377934 | Marketed | |
| CANDESARTAN | 02377942 | Marketed | |
| CANDESARTAN | 02422069 | Marketed | |
| CANDESARTAN-HCTZ | 02392275 | Marketed | |
| CARVEDILOL | 02324504 | Marketed | |
| CARVEDILOL | 02324512 | Marketed | |
| CARVEDILOL | 02324520 | Marketed | |
| CARVEDILOL | 02324539 | Marketed | |
| CELECOXIB | 02424371 | Marketed | |
| CELECOXIB | 02424398 | Marketed | |
| CLOPIDOGREL | 02394820 | Marketed | |
| DESVENLAFAXINE | 02543672 | Marketed | |
| DESVENLAFAXINE | 02543680 | Marketed | |
| DOXYTAB | 00887064 | Marketed | |
| ESCITALOPRAM | 02424401 | Marketed | |
| ESCITALOPRAM | 02424428 | Marketed | |
| ESOMEPRAZOLE | 02394839 | Marketed | |
| ESOMEPRAZOLE | 02394847 | Marketed | |
| EZETIMIBE | 02422549 | Marketed | |
| HYDROCHLOROTHIAZIDE | 02486962 | Marketed | |
| LAMOTRIGINE-100 | 02302985 | Marketed | |
| LAMOTRIGINE-150 | 02302993 | Marketed | |
| LAMOTRIGINE-25 | 02302969 | Marketed | |
| LETROZOLE | 02402025 | Marketed | |
| LOPERAMIDE-2 | 02225182 | Marketed | |
| MONTELUKAST | 02379821 | Marketed | |
| MONTELUKAST | 02379848 | Marketed | |
| MONTELUKAST | 02379856 | Marketed | |
| MOXIFLOXACIN | 02462974 | Marketed | |
| NAPROXEN-NA | 00887056 | Marketed | |
| NAPROXEN-NA DF | 02153386 | Marketed | |
| NIFEDIPINE ER | 02421658 | Marketed | |
| OLANZAPINE | 02311968 | Marketed | |
| OLANZAPINE | 02311976 | Marketed | |
| OLANZAPINE | 02311984 | Marketed | |
| OLANZAPINE | 02311992 | Marketed | |
| OLANZAPINE | 02312018 | Marketed | |
| OLANZAPINE | 02421704 | Marketed | |
| OLANZAPINE ODT | 02338645 | Marketed | |
| OLANZAPINE ODT | 02338653 | Marketed | |
| OLANZAPINE ODT | 02338661 | Marketed | |
| OLMESARTAN | 02488744 | Marketed | |
| OLMESARTAN | 02488752 | Marketed | |
| OMEPRAZOLE | 02339927 | Marketed | |
| ONDANSETRON | 02325160 | Marketed | |
| PANTOPRAZOLE | 02318695 | Marketed | |
| PERINDOPRIL ERBUMINE | 02488949 | Marketed | |
| PERINDOPRIL ERBUMINE | 02488957 | Marketed | |
| PERINDOPRIL ERBUMINE | 02488965 | Marketed | |
| PERINDOPRIL ERBUMINE/INDAPAMIDE | 02523035 | Marketed | |
| PERINDOPRIL ERBUMINE/INDAPAMIDE HD | 02523043 | Marketed | |
| PRAMIPEXOLE | 02325802 | Marketed | |
| PRAMIPEXOLE | 02325810 | Marketed | |
| PRAMIPEXOLE | 02325829 | Marketed | |
| PRAMIPEXOLE | 02325837 | Marketed | |
| PREGABALIN | 02396483 | Marketed | |
| PREGABALIN | 02396505 | Marketed | |
| PREGABALIN | 02396513 | Marketed | |
| PREGABALIN | 02396521 | Marketed | |
| PREGABALIN | 02396548 | Marketed | |
| PRO-AAS - 80 (CROQUABLE) | 02311518 | Marketed | |
| PRO-AAS EC - 80 | 02311496 | Marketed | |
| PRO-ALPRAZOLAM | 01908189 | Marketed | |
| PRO-ALPRAZOLAM | 01908170 | Marketed | |
| PRO-ALPRAZOLAM | 02248706 | Marketed | |
| PRO-AMIODARONE - 200 | 02309661 | Marketed | |
| PRO-AMITRIPTYLINE | 00370991 | Marketed | |
| PRO-AMITRIPTYLINE | 00371009 | Marketed | |
| PRO-AMITRIPTYLINE | 00456349 | Marketed | |
| PRO-AMOX-250 | 00644331 | Marketed | |
| PRO-AMOX-500 | 00644315 | Marketed | |
| PRO-AMOXI CLAV | 02536498 | Marketed | |
| PRO-AMOXI CLAV | 02536501 | Marketed | |
| PRO-ANASTROZOLE | 02395649 | Marketed | |
| PRO-APIXABAN | 02530724 | Marketed | |
| PRO-APIXABAN | 02530732 | Marketed | |
| PRO-ATENOLOL | 00828793 | Marketed | |
| PRO-ATENOLOL | 00828807 | Marketed | |
| PRO-ATENOLOL | 02326701 | Marketed | |
| PRO-ATOMOXETINE | 02396904 | Marketed | |
| PRO-ATOMOXETINE | 02396912 | Marketed | |
| PRO-ATOMOXETINE | 02396920 | Marketed | |
| PRO-ATOMOXETINE | 02396939 | Marketed | |
| PRO-ATOMOXETINE | 02396947 | Marketed | |
| PRO-ATORVASTATIN | 02346486 | Marketed | |
| PRO-ATORVASTATIN | 02346494 | Marketed | |
| PRO-ATORVASTATIN | 02346508 | Marketed | |
| PRO-ATORVASTATIN | 02346516 | Marketed | |
| PRO-AZITHROMYCINE | 02310600 | Marketed | |
| PRO-BACLOFEN | 02152584 | Marketed | |
| PRO-BACLOFEN | 02152592 | Marketed | |
| PRO-BICALUTAMIDE | 02311038 | Marketed | |
| PRO-BIMATOPROST RC | 02563428 | Marketed | |
| PRO-BISOPROLOL | 02306999 | Marketed | |
| PRO-BISOPROLOL | 02307006 | Marketed | |
| PRO-BUSPIRONE | 02223163 | Marketed | |
| PRO-CEPHALEXIN | 02562596 | Marketed | |
| PRO-CETIRIZINE | 02450526 | Marketed | |
| PRO-CIPROFLOXACIN | 02317796 | Marketed | |
| PRO-CIPROFLOXACIN | 02317818 | Marketed | |
| PRO-CITALOPRAM | 02257513 | Marketed | |
| PRO-CITALOPRAM | 02257521 | Marketed | |
| PRO-CITALOPRAM | 02325047 | Marketed | |
| PRO-CLARITHROMYCIN | 02324482 | Marketed | |
| PRO-CLARITHROMYCIN | 02324490 | Marketed | |
| PRO-CYCLOBENZAPRINE | 02220644 | Marketed | |
| PRO-DAPAGLIFLOZIN | 02537656 | Marketed | |
| PRO-DAPAGLIFLOZIN | 02537664 | Marketed | |
| PRO-DICLOFENAC | 00870978 | Marketed | |
| PRO-DILTIAZEM CD | 02540924 | Marketed | |
| PRO-DILTIAZEM CD | 02540932 | Marketed | |
| PRO-DILTIAZEM CD | 02540940 | Marketed | |
| PRO-DILTIAZEM CD | 02540959 | Marketed | |
| PRO-DOMPERIDONE | 02236857 | Marketed | |
| PRO-DONEPEZIL | 02416417 | Marketed | |
| PRO-DONEPEZIL | 02416425 | Marketed | |
| PRO-DULOXETINE | 02452650 | Marketed | |
| PRO-DULOXETINE | 02452669 | Marketed | |
| PRO-DUTASTERIDE | 02543990 | Marketed | |
| PRO-EDOXABAN | 02556960 | Marketed | |
| PRO-EDOXABAN | 02556979 | Marketed | |
| PRO-ELETRIPTAN | 02489961 | Marketed | |
| PRO-ELETRIPTAN | 02489988 | Marketed | |
| PRO-ENALAPRIL - 10 | 02311429 | Marketed | |
| PRO-ENALAPRIL - 2.5 | 02311402 | Marketed | |
| PRO-ENALAPRIL - 20 | 02311437 | Marketed | |
| PRO-ENALAPRIL - 5 | 02311410 | Marketed | |
| PRO-FINASTERIDE | 02350270 | Marketed | |
| PRO-FLUCONAZOLE | 02310686 | Marketed | |
| PRO-FLUOXETINE | 02314991 | Marketed | |
| PRO-FLUOXETINE | 02315009 | Marketed | |
| PRO-FUROSEMIDE | 00397792 | Marketed | |
| PRO-FUROSEMIDE | 00496723 | Marketed | |
| PRO-FUROSEMIDE | 00667080 | Marketed | |
| PRO-GABAPENTIN | 02310449 | Marketed | |
| PRO-GABAPENTIN | 02310457 | Marketed | |
| PRO-GABAPENTIN | 02310465 | Marketed | |
| PRO-GABAPENTIN | 02310473 | Marketed | |
| PRO-GABAPENTIN | 02310481 | Marketed | |
| PRO-GUANFACINE XR | 02525224 | Marketed | |
| PRO-GUANFACINE XR | 02525232 | Marketed | |
| PRO-GUANFACINE XR | 02525240 | Marketed | |
| PRO-GUANFACINE XR | 02525259 | Marketed | |
| PRO-IRBESARTAN | 02365197 | Marketed | |
| PRO-IRBESARTAN | 02365200 | Marketed | |
| PRO-IRBESARTAN | 02365219 | Marketed | |
| PRO-IRBESARTAN-HCTZ | 02365162 | Marketed | |
| PRO-IRBESARTAN-HCTZ | 02365170 | Marketed | |
| PRO-IRBESARTAN-HCTZ | 02365189 | Marketed | |
| PRO-ISMN - 60 | 02311321 | Marketed | |
| PRO-LANSOPRAZOLE | 02366282 | Marketed | |
| PRO-LEFLUNOMIDE | 02415828 | Marketed | |
| PRO-LEFLUNOMIDE | 02415836 | Marketed | |
| PRO-LEVETIRACETAM - 250 | 02311372 | Marketed | |
| PRO-LEVETIRACETAM - 500 | 02311380 | Marketed | |
| PRO-LEVETIRACETAM - 750 | 02311399 | Marketed | |
| PRO-LEVOFLOXACIN | 02415879 | Marketed | |
| PRO-LISDEXAMFETAMINE | 02547031 | Marketed | |
| PRO-LISDEXAMFETAMINE | 02547058 | Marketed | |
| PRO-LISDEXAMFETAMINE | 02547066 | Marketed | |
| PRO-LISDEXAMFETAMINE | 02547074 | Marketed | |
| PRO-LISDEXAMFETAMINE | 02547082 | Marketed | |
| PRO-LISDEXAMFETAMINE | 02547090 | Marketed | |
| PRO-LISDEXAMFETAMINE | 02547104 | Marketed | |
| PRO-LORAZEPAM | 00655643 | Marketed | |
| PRO-LORAZEPAM | 00655651 | Marketed | |
| PRO-LORAZEPAM | 00655678 | Marketed | |
| PRO-METFORMIN | 02314894 | Marketed | |
| PRO-METFORMIN | 02314908 | Marketed | |
| PRO-METOPROLOL | 02296713 | Marketed | |
| PRO-METOPROLOL-L | 00648019 | Marketed | |
| PRO-METOPROLOL-L | 00648027 | Marketed | |
| PRO-MIRTAZAPINE | 02312778 | Marketed | |
| PRO-MIRTAZAPINE | 02312786 | Marketed | |
| PRO-NAPROXEN EC | 02310953 | Marketed | |
| PRO-NIFEDIPINE ER | 02534843 | Marketed | |
| PRO-OLANZAPINE ODT | 02425114 | Marketed | |
| PRO-OXAZEPAM | 00497754 | Marketed | |
| PRO-OXAZEPAM | 00497762 | Marketed | |
| PRO-OXAZEPAM | 00497770 | Marketed | |
| PRO-PAROXETINE | 02248913 | Marketed | |
| PRO-PAROXETINE | 02248914 | Marketed | |
| PRO-PAROXETINE | 02248915 | Marketed | |
| PRO-PRAVASTATIN | 02243824 | Marketed | |
| PRO-PRAVASTATIN | 02243825 | Marketed | |
| PRO-PRAVASTATIN | 02243826 | Marketed | |
| PRO-QUETIAPINE | 02317346 | Marketed | |
| PRO-QUETIAPINE | 02317354 | Marketed | |
| PRO-QUETIAPINE | 02317362 | Marketed | |
| PRO-QUETIAPINE | 02317370 | Marketed | |
| PRO-QUININE - 200 | 02311216 | Marketed | |
| PRO-QUININE - 300 | 02311224 | Marketed | |
| PRO-RAMIPRIL - 1.25 | 02310023 | Marketed | |
| PRO-RAMIPRIL - 10 | 02310104 | Marketed | |
| PRO-RAMIPRIL - 2.5 | 02310066 | Marketed | |
| PRO-RAMIPRIL - 5 | 02310074 | Marketed | |
| PRO-RISPERIDONE | 02312700 | Marketed | |
| PRO-RISPERIDONE | 02312719 | Marketed | |
| PRO-RISPERIDONE | 02312727 | Marketed | |
| PRO-RISPERIDONE | 02312735 | Marketed | |
| PRO-RISPERIDONE | 02312743 | Marketed | |
| PRO-RISPERIDONE | 02312751 | Marketed | |
| PRO-RIVAROXABAN | 02540967 | Marketed | |
| PRO-RIVAROXABAN | 02540975 | Marketed | |
| PRO-RIVAROXABAN | 02540983 | Marketed | |
| PRO-RIVAROXABAN | 02540991 | Marketed | |
| PRO-ROSUVASTATIN | 02381176 | Marketed | |
| PRO-ROSUVASTATIN | 02381184 | Marketed | |
| PRO-ROSUVASTATIN | 02381192 | Marketed | |
| PRO-ROSUVASTATIN | 02381206 | Marketed | |
| PRO-SERTRALINE | 02241302 | Marketed | |
| PRO-SERTRALINE | 02241303 | Marketed | |
| PRO-SERTRALINE | 02241304 | Marketed | |
| PRO-SIMVASTATIN | 02247221 | Marketed | |
| PRO-SIMVASTATIN | 02247222 | Marketed | |
| PRO-SIMVASTATIN | 02247223 | Marketed | |
| PRO-SIMVASTATIN | 02247224 | Marketed | |
| PRO-SITAGLIPTIN | 02553376 | Marketed | |
| PRO-SITAGLIPTIN | 02553384 | Marketed | |
| PRO-SITAGLIPTIN | 02553392 | Marketed | |
| PRO-SITAGLIPTIN-METFORMIN | 02552817 | Marketed | |
| PRO-SITAGLIPTIN-METFORMIN | 02552825 | Marketed | |
| PRO-SITAGLIPTIN-METFORMIN | 02552833 | Marketed | |
| PRO-SUMATRIPTAN | 02324652 | Marketed | |
| PRO-SUMATRIPTAN | 02324660 | Marketed | |
| PRO-TELMISARTAN-HCTZ | 02395525 | Marketed | |
| PRO-TELMISARTAN-HCTZ | 02395533 | Marketed | |
| PRO-TOPIRAMATE | 02313650 | Marketed | |
| PRO-TOPIRAMATE | 02313669 | Marketed | |
| PRO-TOPIRAMATE | 02313677 | Marketed | |
| PRO-VALACYCLOVIR | 02315173 | Marketed | |
| PRO-ZOLPIDEM ODT | 02537346 | Marketed | |
| PRO-ZOLPIDEM ODT | 02537354 | Marketed | |
| PRO-ZOPICLONE | 02313065 | Marketed | |
| PRO-ZOPICLONE | 02313073 | Marketed | |
| QUETIAPINE XR | 02417782 | Marketed | |
| QUETIAPINE XR | 02417790 | Marketed | |
| QUETIAPINE XR | 02417804 | Marketed | |
| QUETIAPINE XR | 02417812 | Marketed | |
| QUETIAPINE XR | 02417820 | Marketed | |
| REPAGLINIDE | 02415968 | Marketed | |
| REPAGLINIDE | 02415976 | Marketed | |
| REPAGLINIDE | 02415984 | Marketed | |
| RISEDRONATE | 02347474 | Marketed | |
| RIZATRIPTAN RDT | 02415798 | Marketed | |
| RIZATRIPTAN RDT | 02415801 | Marketed | |
| SILDENAFIL | 02424312 | Marketed | |
| SILDENAFIL | 02424320 | Marketed | |
| SOLIFENACIN | 02458144 | Marketed | |
| SOLIFENACIN | 02458152 | Marketed | |
| TADALAFIL | 02455358 | Marketed | |
| TADALAFIL | 02455366 | Marketed | |
| TADALAFIL | 02455374 | Marketed | |
| TAMSULOSIN CR | 02413612 | Marketed | |
| TELMISARTAN | 02395223 | Marketed | |
| TELMISARTAN | 02395231 | Marketed | |
| TERBINAFINE-250 | 02242735 | Marketed | |
| TRANDOLAPRIL | 02488698 | Marketed | |
| TRANDOLAPRIL | 02488701 | Marketed | |
| TRANDOLAPRIL | 02488728 | Marketed | |
| TRAZODONE-100 | 02164361 | Marketed | |
| TRAZODONE-150 D | 02164388 | Marketed | |
| TRAZODONE-50 | 02164353 | Marketed | |
| VALSARTAN | 02367726 | Marketed | |
| VALSARTAN | 02367734 | Marketed | |
| VALSARTAN | 02367742 | Marketed | |
| VALSARTAN | 02367750 | Marketed | |
| VALSARTAN-HCTZ | 02367769 | Marketed | |
| VALSARTAN-HCTZ | 02367777 | Marketed | |
| VALSARTAN-HCTZ | 02367785 | Marketed | |
| VENLAFAXINE XR | 02339242 | Marketed | |
| VENLAFAXINE XR | 02339250 | Marketed | |
| VENLAFAXINE XR | 02339269 | Marketed | |
| VITAMINE D 10 000 | 02417995 | Marketed | |
| ALENDRONATE-10 | 02544288 | Approved | |
| ALENDRONATE-40 | 02544296 | Approved | |
| ALENDRONATE-5 | 02544261 | Approved | |
| FLUOXETINE-20 | 02561425 | Approved | |
| GABAPENTIN | 02568845 | Approved | |
| GABAPENTIN | 02568853 | Approved | |
| GABAPENTIN | 02568861 | Approved | |
| HYDROCHLOROTHIAZIDE | 02486970 | Approved | |
| NIFEDIPINE ER | 02421631 | Dormant | |
| NIFEDIPINE ER | 02441403 | Approved | |
| ONDANSETRON | 02542919 | Approved | |
| PANTOPRAZOLE | 02318687 | Approved |
Showing 300 of 776 drug products. For the rest, search Health Canada’s database.
Notices of Compliance
Newest first.
- PRO-METOPROLOL; PRO-METOPROLOL-LOctober 7, 2026 · NOC 38422 · Supplement to a New Drug Submission (SNDS)
- PRO-NAPROXEN; PRO-NAPROXEN ECOctober 5, 2026 · NOC 38409 · Supplement to a New Drug Submission (SNDS)
- PRO-ROSUVASTATINSeptember 28, 2026 · NOC 38375 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-CIPROFLOXACIN; PRO-CIPROFLOXACIN INTRAVENOUS INFUSION BPSeptember 25, 2026 · NOC 38348 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-SUMATRIPTANSeptember 1, 2026 · NOC 38209 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DOXYTABAugust 21, 2026 · NOC 38156 · Supplement to a New Drug Submission (SNDS)
- PRO-CYCLOBENZAPRINEAugust 18, 2026 · NOC 38126 · Supplement to a New Drug Submission (SNDS)
- PRO-GABAPENTINAugust 7, 2026 · NOC 38068 · Abbreviated New Drug Submission (ANDS)
- PRO-ZOPICLONEAugust 6, 2026 · NOC 38061 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-LEFLUNOMIDEAugust 6, 2026 · NOC 38064 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-DOXYLAMINE-PYRIDOXINEAugust 4, 2026 · NOC 38044 · New Drug Submission (NDS)
- PRO-BISOPROLOLJuly 30, 2026 · NOC 38027 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-GUANFACINE XRJuly 29, 2026 · NOC 38018 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-CITALOPRAMJuly 27, 2026 · NOC 37996 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-IRBESARTANJuly 20, 2026 · NOC 37945 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-ATOMOXETINEJuly 13, 2026 · NOC 37895 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-RIVAROXABANJune 30, 2026 · NOC 37813 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-ATORVASTATINJune 23, 2026 · NOC 37762 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-TOPIRAMATEJune 18, 2026 · NOC 37728 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-ENZALUTAMIDEJune 16, 2026 · NOC 37712 · Abbreviated New Drug Submission (ANDS)
- GABAPENTIN; PRO-GABAPENTINJune 8, 2026 · NOC 37676 · Abbreviated New Drug Submission (ANDS)
- PRO-LEVOCARBJune 8, 2026 · NOC 37679 · New Drug Submission (NDS)
- PRO-LISDEXAMFETAMINEJune 5, 2026 · NOC 37661 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-ESOMEPRAZOLEMay 14, 2026 · NOC 37556 · Abbreviated New Drug Submission (ANDS)
- PRO-FINASTERIDEMay 7, 2026 · NOC 37496 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DOXYTABMay 1, 2026 · NOC 37458 · Supplement to a New Drug Submission (SNDS)
- PRO-GABAPENTINMay 1, 2026 · NOC 37463 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-OLANZAPINE ODTApril 15, 2026 · NOC 37325 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-APIXABANApril 10, 2026 · NOC 37296 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-DILTIAZEM CDMarch 26, 2026 · NOC 37197 · Supplement to a New Drug Submission (SNDS)
- PRO-IRBESARTAN-HCTZMarch 20, 2026 · NOC 37142 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-SERTRALINEMarch 20, 2026 · NOC 37148 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-BIMATOPROST RCMarch 16, 2026 · NOC 37103 · Abbreviated New Drug Submission (ANDS)
- PRO-MOMETASONEMarch 10, 2026 · NOC 37071 · Abbreviated New Drug Submission (ANDS)
- PRO-BICALUTAMIDEMarch 10, 2026 · NOC 37072 · Abbreviated New Drug Submission (ANDS)
- PRO-SITAGLIPTIN-METFORMINMarch 3, 2026 · NOC 37029 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-LEVOFLOXACINFebruary 3, 2026 · NOC 36827 · Abbreviated New Drug Submission (ANDS)
- PRO-ELETRIPTANJanuary 22, 2026 · NOC 36776 · Abbreviated New Drug Submission (ANDS)
- LAMOTRIGINE-100; LAMOTRIGINE-150; LAMOTRIGINE-25January 10, 2026 · NOC 36743 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-GABAPENTINJanuary 7, 2026 · NOC 36696 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-PRAVASTATINDecember 29, 2025 · NOC 36668 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-CLARITHROMYCINDecember 23, 2025 · NOC 36622 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-AMOX-125; PRO-AMOX-250; PRO-AMOX-500December 5, 2025 · NOC 36483 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-LEFLUNOMIDENovember 27, 2025 · NOC 36439 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-DAPAGLIFLOZINNovember 18, 2025 · NOC 36395 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-AZITHROMYCINENovember 18, 2025 · NOC 36397 · Abbreviated New Drug Submission (ANDS)
- PRO-CEPHALEXINOctober 30, 2025 · NOC 36289 · Abbreviated New Drug Submission (ANDS)
- PRO-ANASTROZOLEOctober 30, 2025 · NOC 36300 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-PAROXETINEOctober 16, 2025 · NOC 36181 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-DULOXETINEOctober 10, 2025 · NOC 36154 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-DONEPEZILOctober 2, 2025 · NOC 36096 · Supplement to an Abbreviated New Drug Submission (SANDS)
- FLUOXETINE-20; PRO-FLUOXETINESeptember 26, 2025 · NOC 36063 · Abbreviated New Drug Submission (ANDS)
- PRO-DOMPERIDONESeptember 22, 2025 · NOC 36041 · Abbreviated New Drug Submission (ANDS)
- PRO-ATENOLOLSeptember 15, 2025 · NOC 36002 · Abbreviated New Drug Submission (ANDS)
- PRO-ATENOLOLSeptember 15, 2025 · NOC 36003 · New Drug Submission (NDS)
- PRO-ROSUVASTATINSeptember 3, 2025 · NOC 35954 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-SITAGLIPTINAugust 27, 2025 · NOC 35910 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-AMOXI CLAVJuly 4, 2025 · NOC 35609 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-CETIRIZINEJuly 4, 2025 · NOC 35615 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-METOPROLOL; PRO-METOPROLOL-LJune 27, 2025 · NOC 35592 · Supplement to a New Drug Submission (SNDS)
- PRO-ELETRIPTANJune 11, 2025 · NOC 35664 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-SIMVASTATINJune 3, 2025 · NOC 35464 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-TELMISARTAN-HCTZMay 29, 2025 · NOC 35443 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-ZOPICLONEMay 20, 2025 · NOC 35378 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-EDOXABANMay 5, 2025 · NOC 35301 · Abbreviated New Drug Submission (ANDS)
- PRO-CYCLOBENZAPRINEApril 30, 2025 · NOC 35275 · Supplement to a New Drug Submission (SNDS)
- PRO-PRAVASTATINApril 17, 2025 · NOC 35208 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-BACLOFENApril 17, 2025 · NOC 35225 · Supplement to a New Drug Submission (SNDS)
- PRO-LANSOPRAZOLEApril 11, 2025 · NOC 35170 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-DICLOFENACApril 11, 2025 · NOC 35171 · Supplement to a New Drug Submission (SNDS)
- PRO-FLUCONAZOLEFebruary 18, 2025 · NOC 34854 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PREGABALINJanuary 30, 2025 · NOC 34760 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-METFORMINJanuary 29, 2025 · NOC 34753 · Abbreviated New Drug Submission (ANDS)
- ROSUVASTATINJanuary 24, 2025 · NOC 34733 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LAMOTRIGINE-100; LAMOTRIGINE-150; LAMOTRIGINE-25December 27, 2024 · NOC 34656 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TERBINAFINE-250December 20, 2024 · NOC 34588 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DESVENLAFAXINEDecember 19, 2024 · NOC 34589 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-RIVAROXABANDecember 18, 2024 · NOC 34569 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-GABAPENTINDecember 10, 2024 · NOC 34533 · Supplement to an Abbreviated New Drug Submission (SANDS)
- OLANZAPINE; OLANZAPINE ODTDecember 4, 2024 · NOC 34484 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ONDANSETRONNovember 28, 2024 · NOC 34464 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-SITAGLIPTINNovember 18, 2024 · NOC 34398 · Abbreviated New Drug Submission (ANDS)
- PRO-SITAGLIPTIN-METFORMINNovember 6, 2024 · NOC 34334 · Abbreviated New Drug Submission (ANDS)
- LEVOFLOXACINOctober 18, 2024 · NOC 34230 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-QUETIAPINEOctober 17, 2024 · NOC 34216 · Abbreviated New Drug Submission (ANDS)
- PRO-FLUOXETINEOctober 15, 2024 · NOC 34197 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-DAPAGLIFLOZINOctober 11, 2024 · NOC 34209 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-GABAPENTINOctober 4, 2024 · NOC 34142 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-AMOXI CLAVOctober 4, 2024 · NOC 34150 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SILDENAFILOctober 2, 2024 · NOC 34123 · Supplement to an Abbreviated New Drug Submission (SANDS)
- BACLOFEN-10; BACLOFEN-20September 27, 2024 · NOC 34100 · Supplement to a New Drug Submission (SNDS)
- EZETIMIBESeptember 23, 2024 · NOC 34070 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TAMSULOSIN CRSeptember 12, 2024 · NOC 33998 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRO-LISINOPRIL - 10; PRO-LISINOPRIL - 20; PRO-LISINOPRIL - 5September 12, 2024 · NOC 34002 · Supplement to a New Drug Submission (SNDS)
- PRO-BUSPIRONEAugust 21, 2024 · NOC 33849 · Abbreviated New Drug Submission (ANDS)
- PRO-MIRTAZAPINEAugust 20, 2024 · NOC 33837 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CITALOPRAM - 10; CITALOPRAM - 20; CITALOPRAM - 40August 14, 2024 · NOC 33815 · Abbreviated New Drug Submission (ANDS)
- PRAMIPEXOLEAugust 13, 2024 · NOC 33810 · Supplement to an Abbreviated New Drug Submission (SANDS)
- VENLAFAXINE XRJuly 25, 2024 · NOC 33716 · Supplement to an Abbreviated New Drug Submission (SANDS)
- OMEPRAZOLEJuly 19, 2024 · NOC 33683 · Supplement to an Abbreviated New Drug Submission (SANDS)
The latest 100 of 600.
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- PRO-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit for N-nitroso-fluoxetineJune 30, 2025 · Drugs · Product quality · Type I
- PRO-FLUOXETINE: Affected lots exceed the interim acceptable intake limit for N-nitroso-fluoxetine.April 28, 2025 · Drugs · Product quality · Type I
- PRO-AAS EC 80: out of specificationNovember 8, 2023 · Drugs · Product quality · Type II
- Sanis Health Losartan / Losartan-HCTZ Product Recall (2021-09-10)September 16, 2021 · Drugs · Product safety · Type I
- PRO-Ciprofloxacin 250mg Tablet (2018-08-09)August 9, 2018 · Drugs · Product safety · Type II
- pro-Clonazepam (2016-09-06)September 20, 2016 · Drugs · Product safety · Type II
- PRO-Zopiclone (2015-09-24)October 6, 2015 · Drugs · Product safety · Type II
- Losartan-HCTZ (2015-06-03)June 4, 2015 · Drugs · Product safety · Type III
- Diltiazem-CD 300 mg capsules (2014-02-20)March 14, 2014 · Drugs · Product safety · Type III
- PRO-Risperidone 0.5 mgOctober 29, 2012 · Drugs · Dosage · Type II